Copyright © 2005, European Society of Cardiology
Angiotensin II-evoked enhanced expression of RGS2 attenuates Gi-mediated adenylyl cyclase signaling in A10 cells
Department of Physiology, Faculty of Medicine, University of Montreal, and Groupe de recherche sur le système nerveux autonome (GRSNA), Canada
* Corresponding author. Department of Physiology, Faculty of Medicine, University of Montreal, C.P. 6128, Succ. Centre-ville, Montreal, Quebec, Canada, H3C 3J7. Tel.: +1 514 343 2091; fax: +1 514 343 2111. Email address: anandsrm{at}physio.umontreal.ca
Objective: We have recently shown that pretreatment of A10 vascular smooth muscle cells (VSMC) with angiotensin II (Ang II) for 24 h enhanced the expression of Gi
-proteins, however, Gi-mediated adenylyl cyclase signaling was attenuated. Since regulators of G-protein signaling (RGS) have been shown to negatively regulate the G-protein, we investigated the role of RGS2, in Ang II-induced attenuation of Gi-mediated signaling in A10 vascular smooth muscle cells (VSMC).
Methods: A10 VSMC were incubated with Ang II (10–7 M) for different periods of time at 37 °C. The levels of G-proteins and RGS2 protein were determined by immunoblotting using specific antibodies. Adenylyl cyclase activity stimulated or inhibited by agonists was determined to examine the functions of G-proteins.
Results: Ang II treatment of A10 VSMC enhanced the expression of Gi and RGS2 proteins in a time-dependent manner, the maximal expression of Gi-proteins was observed at 1 h that remained elevated up to 24 h, whereas enhanced expression of RGS2 in these cells was detected at 1 h, peaked at 2 h and returned to base line level by 8 h. The increased expression of RGS2 by Ang II was inhibited by actinomycin D. The increased expression of Gi at 30 min when the levels of RGS2 were not augmented was reflected in increased Gi functions as was demonstrated by increased inhibition of adenylyl cyclase by inhibitory hormones (receptor-dependent functions) and increased inhibition of forskolin (FSK)-stimulated adenylyl cyclase by GTP
S (receptor-independent functions). However, with increased expression of RGS2, the Gi-mediated functions started declining and were completely abolished at 2 h of treatment when the levels of RGS2 were maximally augmented. Furthermore, prior treatment of cells with RGS2 antibody, that completely attenuated Ang II-induced expression of RGS2, prevented the GTPS-induced attenuation of FSK-stimulated adenylyl cyclase activity. In addition, treatment of the cells with Ang II for 30 min that increased the levels of Gi-protein and not of RGS2 protein resulted in the attenuation of Gs-mediated isoproterenol-induced stimulation of adenylyl cyclase and this attenuation was restored to control level at 1 h and remained unchanged thereafter.
Conclusion: These results suggest that RGS2 may be involved in short-term regulation of Ang II-induced Gi-mediated adenylyl cyclase signalling.
KEYWORDS RGS2 protein; G-protein; Adenylyl cyclase; Angiotensin II; VSMC
Abbreviations: C-ANP4–23, [des(Glu18, Ser19, Glu20, Leuc21, Gly22) ANP4–23-NH2] • VSMC, vascular smooth muscle cells • RGS2, regulator of G-protein signaling • Ang II, angiotensin II • Gi, inhibitory guanine nucleotide regulatory protein • Gs, stimulatory guanine nucleotide regulatory protein • GTPS, guanosine 5'--thiotriphosphate
* This study was supported by a grant from Canadian Institutes of Health Research (MOP 53074).
Time for primary review 31 days
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Lelonek, T. Pietrucha, M. Matyjaszczyk, and J. H. Goch A novel approach to syncopal patients: association analysis of polymorphisms in G-protein genes and tilt outcome Europace, January 1, 2009; 11(1): 89 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. C. da Costa-Goncalves, J. Tank, R. Plehm, A. Diedrich, M. Todiras, M. Gollasch, A. Heuser, M. Wellner, M. Bader, J. Jordan, et al. Role of the Multidomain Protein Spinophilin in Blood Pressure and Cardiac Function Regulation Hypertension, October 1, 2008; 52(4): 702 - 707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. C. Hercule, J. Tank, R. Plehm, M. Wellner, A. C. da Costa Goncalves, M. Gollasch, A. Diedrich, J. Jordan, F. C. Luft, and V. Gross Cardiovascular Control: Regulator of G protein signalling 2 ameliorates angiotensin II-induced hypertension in mice Exp Physiol, November 1, 2007; 92(6): 1014 - 1022. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Z. Xie, M. C. Gong, W. Su, J. Turk, and Z. Guo Group VIA Phospholipase A2 (iPLA2beta) Participates in Angiotensin II-induced Transcriptional Up-regulation of Regulator of G-protein Signaling-2 in Vascular Smooth Muscle Cells J. Biol. Chem., August 31, 2007; 282(35): 25278 - 25289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Liu, E. Y. Yuen, P. B. Allen, J. Feng, P. Greengard, and Z. Yan Adrenergic modulation of NMDA receptors in prefrontal cortex is differentially regulated by RGS proteins and spinophilin PNAS, November 28, 2006; 103(48): 18338 - 18343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Romero, M. W. Plonczynski, E. P. Gomez-Sanchez, L. L. Yanes, and C. E. Gomez-Sanchez RGS2 Is Regulated by Angiotensin II and Functions as a Negative Feedback of Aldosterone Production in H295R Human Adrenocortical Cells Endocrinology, August 1, 2006; 147(8): 3889 - 3897. [Abstract] [Full Text] [PDF]
|
|